Arcus Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Arcus Biosciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-25 | $-1.03 | $-1.20 | 14.2 % |
Q3 | 2024-11-06 | $-1.00 | $-1.06 | 5.66 % |
Q2 | 2024-08-08 | $-1.02 | $-1.10 | 7.27 % |
Q1 | 2024-05-08 | $-0.05 | $-0.93 | 94.6 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-25 | $36.00M | $29.38M | 22.5 % |
Q3 | 2024-11-06 | $48.00M | $37.56M | 27.8 % |
Q2 | 2024-08-08 | $39.00M | $25.61M | 52.3 % |
Q1 | 2024-05-08 | $145.00M | $35.56M | 307.8 % |
Arcus Biosciences (RCUS) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on February 25, 2025 for Q4.
The Actual EPS was $-1.03, which beat the estimate of $-1.20.
The Actual Revenue was $36M, which beat the estimate of $29.4M.
Browse earnings estimates, EPS, and revenue on all stocks.